These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12954049)

  • 1. Discovery and preclinical characterization of (+)-3-[4-(1- piperidinoethoxy)phenyl]spiro[indene- 1,1'-indane]-5,5'-diol hydrochloride: a promising nonsteroidal estrogen receptor agonist for hot flush.
    Watanabe N; Ikeno A; Minato H; Nakagawa H; Kohayakawa C; Tsuji J
    J Med Chem; 2003 Sep; 46(19):3961-4. PubMed ID: 12954049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A selective estrogen receptor modulator for the treatment of hot flushes.
    Wallace OB; Lauwers KS; Dodge JA; May SA; Calvin JR; Hinklin R; Bryant HU; Shetler PK; Adrian MD; Geiser AG; Sato M; Burris TP
    J Med Chem; 2006 Feb; 49(3):843-6. PubMed ID: 16451049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of OS-0689, a novel SERM, on periarterial nerve function in tail arteries of ovariectomized rats.
    Minato H; Ikeno A; Watanabe N; Tsuji J
    Maturitas; 2005 Aug; 51(4):434-41. PubMed ID: 16039418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel chromene-derived selective estrogen receptor modulators useful for alleviating hot flushes and vaginal dryness.
    Jain N; Kanojia RM; Xu J; Jian-Zhong G; Pacia E; Lai MT; Du F; Musto A; Allan G; Hahn D; Lundeen S; Sui Z
    J Med Chem; 2006 Jun; 49(11):3056-9. PubMed ID: 16722623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and structure-activity relationships of chromene-derived selective estrogen receptor modulators for treatment of postmenopausal symptoms.
    Jain N; Xu J; Kanojia RM; Du F; Jian-Zhong G; Pacia E; Lai MT; Musto A; Allan G; Reuman M; Li X; Hahn D; Cousineau M; Peng S; Ritchie D; Russell R; Lundeen S; Sui Z
    J Med Chem; 2009 Dec; 52(23):7544-69. PubMed ID: 19366247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lasofoxifene, a next generation estrogen receptor modulator: preclinical studies].
    Maeda T; Ke HZ; Simmons H; Thompson D
    Clin Calcium; 2004 Oct; 14(10):85-93. PubMed ID: 15577137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of OS-0544, a selective estrogen receptor modulator, on endothelial function and increased sympathetic activity in ovariectomized rats.
    Ikeno A; Minato H; Kohayakawa C; Tsuji J
    Vascul Pharmacol; 2009; 50(1-2):40-4. PubMed ID: 18854227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the traditional Japanese medicine Tokaku-jyoki-to in rat-models for menopausal hot flash.
    Noguchi M; Yuzurihara M; Ikarashi Y; Tsuchiya N; Hibino T; Mase A; Kase Y
    J Ethnopharmacol; 2009 Oct; 126(1):96-101. PubMed ID: 19682564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and preclinical pharmacology of a novel, potent, nonsteroidal estrogen receptor agonist/antagonist, CP-336156, a diaryltetrahydronaphthalene.
    Rosati RL; Da Silva Jardine P; Cameron KO; Thompson DD; Ke HZ; Toler SM; Brown TA; Pan LC; Ebbinghaus CF; Reinhold AR; Elliott NC; Newhouse BN; Tjoa CM; Sweetnam PM; Cole MJ; Arriola MW; Gauthier JW; Crawford DT; Nickerson DF; Pirie CM; Qi H; Simmons HA; Tkalcevic GT
    J Med Chem; 1998 Jul; 41(16):2928-31. PubMed ID: 9685230
    [No Abstract]   [Full Text] [Related]  

  • 10. The combination of a novel selective estrogen receptor modulator with an estrogen protects the mammary gland and uterus in a rodent model: the future of postmenopausal women's health?
    Labrie F; El-Alfy M; Berger L; Labrie C; Martel C; Bélanger A; Candas B; Pelletier G
    Endocrinology; 2003 Nov; 144(11):4700-6. PubMed ID: 12960051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 3-phenyl-4-[[4-[2-(1-piperidinyl)ethoxy]phenyl]methyl]- 2H-1-benzopyran-7-ol (CHF 4056), a novel nonsteroidal estrogen agonist/antagonist, on reproductive and nonreproductive tissue.
    Galbiati E; Caruso PL; Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M
    J Pharmacol Exp Ther; 2002 Mar; 300(3):802-9. PubMed ID: 11861784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats.
    Hummel CW; Geiser AG; Bryant HU; Cohen IR; Dally RD; Fong KC; Frank SA; Hinklin R; Jones SA; Lewis G; McCann DJ; Rudmann DG; Shepherd TA; Tian H; Wallace OB; Wang M; Wang Y; Dodge JA
    J Med Chem; 2005 Nov; 48(22):6772-5. PubMed ID: 16250633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic agents for disorders of bone and calcium metabolism: Bazedoxifene].
    Chaki O
    Clin Calcium; 2007 Jan; 17(1):30-5. PubMed ID: 17211091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor ligands. Part 6: Synthesis and binding affinity of dihydrobenzodithiins.
    Tan Q; Birzin ET; Chan W; Yang YT; Pai LY; Hayes EC; DaSilva CA; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3753-5. PubMed ID: 15203156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
    Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
    Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.
    Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Geiser M; Halleux C; Kallen J; Keller H; Ramage P
    J Med Chem; 2005 Jan; 48(2):364-79. PubMed ID: 15658851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Next generation selective estrogen receptor modulators].
    Chaki O
    Clin Calcium; 2006 Jan; 16(1):145-52. PubMed ID: 16397365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor ligands. II. Discovery of benzoxathiins as potent, selective estrogen receptor alpha modulators.
    Kim S; Wu JY; Birzin ET; Frisch K; Chan W; Pai LY; Yang YT; Mosley RT; Fitzgerald PM; Sharma N; Dahllund J; Thorsell AG; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
    J Med Chem; 2004 Apr; 47(9):2171-5. PubMed ID: 15084115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The selective oestrogen receptor modulator, LY362321, is not neuroprotective in a rat model of transient focal ischaemia.
    Farr TD; Carswell HV; McCann DJ; Sato M; Bryant HU; Dodge JA; Macrae IM
    J Neuroendocrinol; 2008 Mar; 20(3):366-74. PubMed ID: 18208545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor ligands. Part 10: Chromanes: old scaffolds for new SERAMs.
    Tan Q; Blizzard TA; Morgan JD; Birzin ET; Chan W; Yang YT; Pai LY; Hayes EC; DaSilva CA; Warrier S; Yudkovitz J; Wilkinson HA; Sharma N; Fitzgerald PM; Li S; Colwell L; Fisher JE; Adamski S; Reszka AA; Kimmel D; DiNinno F; Rohrer SP; Freedman LP; Schaeffer JM; Hammond ML
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1675-81. PubMed ID: 15745820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.